News
"Targeting Transcriptional Addiction in Cancer" (TACTIC) is funded by the DKH!
Within the special funding program: "Preclinical Drug Development" our project TACTIC is funded.
German Cancer Award 2023 (Deutscher Krebspreis) for Christian Reinhardt
For his excellent work in cancer medicine and research, Prof. Dr. Christian Reinhardt receives the…
New Publication by Flümann et al. in Blood Cancer Discovery
Our new manuscript titled "Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive…
Network for drug discovery research has been established in NRW
We are very excited about our participation in the CANTAR network, which just received generous…
SFB1530 receives positive funding decision
The collaborative research center (SFB) 1530 received a positive funding decision and will now start…
New award
Gero Knittel from our lab presented our work on dual targeting of BCL2 and BTK in aggressive…
New collaboration
The MERCUR Foundation granted funding for the collaborative research initiative "Targeting Cancer at…
MRI system M3
Our new small rodent MRI system “M3”, produced by Aspect Imaging, has been successfully installed…